Smart Patients Get Smart Care™

The World’s Leading Authority for Chronic Lymphocytic Leukemia Patients

On Demand Educational Activities

Education On-Demand Education On-Demand The varied educational activities offered by CLL Society are your  opportunities to learn basic information, dive deep into specific topics, or stay abreast of cutting-edge news and

CLL Glossary

CLL Glossary There certainly are many confusing terms in CLL. While this can be overwhelming at first for new patients, we assure you that after a time you will be amazed

ASH2020/EHA 2021: Dr. Jennifer Woyach on Protein Kinase C-Beta Inhibitor MS-553 for Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)

At the annual meeting of the American Society of Hematology (ASH) 2020 our own Dr. Brian Koffman interviewed Dr. Jennifer Woyach, a professor of medicine and hematologist at the James Cancer Center of the Ohio State University. They discussed an ongoing phase 1 clinical trial testing the safety of protein kinase C-beta inhibitor MS-553 in patients with relapsed/refractory CLL. Updated data presented at European Hematology Association (EHA) 2021 are also in the results below.

Recent Publications of Interest for Chronic Lymphocytic Leukemia (CLL) Patients Related to COVID-19

I am introducing eight different research articles and commentaries on COVID-19 that are pertinent to the chronic lymphocytic community, and have informed my personal and institutional response to the demands and opportunities afforded by being one of the most vulnerable during a world-changing pandemic over the past weeks. You can just skim my highlights or use the numerous links to dive deeper.

Didn't find what you where looking for?

Try our advanced search page!